Missed Opportunity or Cause for Concern? Methamphetamine Use Is Associated With Greater Interest in Event-Driven PrEP Among Sexual Minority Men

AIDS Educ Prev. 2024 Aug;36(4):272-284. doi: 10.1521/aeap.2024.36.4.272.

Abstract

Our study assessed the association between methamphetamine (i.e., crystal meth, CM) use and awareness and interest in event-driven (ED) PrEP among HIV-negative and those with unknown serostatus cisgender males and transgender people. We performed log-binomial regression analysis to predict awareness (i.e., having heard of ED PrEP) and being interested in ED PrEP. We found that participants who recently used CM were less likely to know of ED PrEP (aPR = 0.83, 95% CI [0.69, 0.99]) but more interested in ED PrEP (aPR = 1.12, 95% CI [1.01, 1.30]), after accounting for demographic and HIV-related behaviors. Opportunities to expand PrEP uptake and improve adherence among individuals who report CM use are essential to impact the HIV epidemic significantly. Continued research on the needs and best practices to work with this community is needed to ensure a successful rollout and implementation of ED PrEP.

Keywords: HIV prevention; PrEP; PrEP 2-1-1; crystal meth; event-driven PrEP.

MeSH terms

  • Adolescent
  • Adult
  • Amphetamine-Related Disorders / epidemiology
  • Amphetamine-Related Disorders / psychology
  • Anti-HIV Agents
  • HIV Infections* / prevention & control
  • Health Knowledge, Attitudes, Practice*
  • Homosexuality, Male / psychology
  • Homosexuality, Male / statistics & numerical data
  • Humans
  • Male
  • Methamphetamine* / administration & dosage
  • Middle Aged
  • Patient Acceptance of Health Care / psychology
  • Patient Acceptance of Health Care / statistics & numerical data
  • Pre-Exposure Prophylaxis* / methods
  • Sexual and Gender Minorities* / psychology
  • Sexual and Gender Minorities* / statistics & numerical data
  • Transgender Persons / psychology
  • Transgender Persons / statistics & numerical data
  • Young Adult

Substances

  • Methamphetamine
  • Anti-HIV Agents